Crowdfunding Is Coming to Biotech

January 28, 2013 @ 3:32 am By Xconomy

Most biotech pros will shrug, or chuckle, if you ask whether crowdfunding will transform life sciences financing in the U.S.

This, after all, is an industry where you often need to raise at least $50 million or $100 million to even have a chance at developing a new drug or medical device. Scraping together a few thousand bucks from individuals on the Internet isn’t going to go very far. One venture capitalist recently told me, “there are a lot of things I worry about, but crowdfunding isn’t one of them.”

Still, I’ve come around to the idea that crowdfunding is going to be disruptive for biotech investment.

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Oct 23, 2026 vs Jan 1, 2025 - Oct 23, 2025

Number of Filings131Prior 125 +4.8%

Target Raise, Total$3.40BPrior $3.54B -3.9%

	This YTD	Year prior	Change
Filings	131	125	+4.8%
Target raise	$3.40B	$3.54B	-3.9%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes

Article Rating

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments

Newest

Oldest Most Voted